727 related articles for article (PubMed ID: 33194809)
1. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease.
Liu J; Xu F; Nie Z; Shao L
Front Cell Infect Microbiol; 2020; 10():570658. PubMed ID: 33194809
[TBL] [Abstract][Full Text] [Related]
2. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
3. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
4. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
5. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
6. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
7. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
Anis E; Xie A; Brundin L; Brundin P
Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
[TBL] [Abstract][Full Text] [Related]
8. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
9. Prion-like propagation of α-synuclein in the gut-brain axis.
Chen Y; Shao Q; Yuan YH; Chen NH
Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
Mahbub NU; Islam MM; Hong ST; Chung HJ
Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
[TBL] [Abstract][Full Text] [Related]
12. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
13. [Advances in Parkinson's disease induced by α-synuclein transmitted through the gut-brain axis].
Zhou J; Wang Z
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2120-2127. PubMed ID: 35786466
[TBL] [Abstract][Full Text] [Related]
14. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
[TBL] [Abstract][Full Text] [Related]
15. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
[TBL] [Abstract][Full Text] [Related]
16. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
17. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
18. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
19. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
20. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
